drugset
drugset / Press release

Mucosta ophthalmic suspension UD2% releases on January 5, 2012®

2012-01-05 · Otsuka Pharmaceutical Development & Commercialization, Inc. · original otsuka.co.jp ↗

Rebamipide

Otsuka Pharmaceutical Co., Ltd. (Head Office: Chiyoda-ku, Tokyo, Japan; President: Taro Iwamoto) today announced the launch of Mucosta ophthalmic suspension UD 2% for patients with dry eye diagnosed on January 5, 2012 in Japan.

The release as fetched from its publisher. otsuka.co.jp ↗